Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neoplasms 6 Breast Neoplasms 5 Prostatic Neoplasms 4 Hematologic Neoplasms 4 Colorectal Neoplasms 4 Melanoma 3 Lung Neoplasms 3 Pancreatic Neoplasms 2 Malignant Solid Neoplasm 2 Leukemia, Myeloid, Acute 2 Hematopoietic and Lymphatic System Neoplasm 2 Head and Neck Neoplasms 2 COVID-19 2 Urologic Neoplasms 1 Urologic Diseases 1 Urinary Bladder Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Spondylitis, Ankylosing 1 Speech 1 Seroma 1 Rectal Neoplasms 1 Psoriasis 1 Progressive Metastatic Castrate Resistant Prostate Cancer 1 Postoperative Complications 1 Peritoneal Neoplasms 1 Parotid Neoplasms 1 Myeloproliferative Disorders 1 Myelodysplastic Syndromes 1 Lymphoma, T-Cell 1 Lymphoma, Large-Cell, Anaplastic 1

Interventions

Gemcitabine 11 Magnetic Resonance Spectroscopy 10 Specimen Handling 8 Cisplatin 7 pembrolizumab 6 Radiation 5 Mitomycin 4 Fluorouracil 4 Cystoscopy 4 enfortumab vedotin 3 durvalumab 3 dehydroftorafur 3 avelumab 3 Transurethral Resection of Bladder 3 Radiotherapy 3 Platinum 3 Nivolumab 3 Mitozytrex 3 Cystectomy 3 1,2-diaminocyclohexaneplatinum II citrate 3 ulixertinib 2 tremelimumab 2 erdafitinib 2 atezolizumab 2 Paclitaxel 2 Immunoglobulin G 2 Docetaxel 2 Disulfides 2 Carboplatin 2 Biopsy 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Urinary Bladder Neoplasms × Standard of Care × 30 days × Clear all

NCT07524426 2026-05-26

LORUP

Umeå University

Phase NA Recruiting

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡